Please use this identifier to cite or link to this item:
https://repositorio.ufpe.br/handle/123456789/61774
Share on
| Title: | Antitumour Testosterone-(Radioactive Iodine) Compound |
| Authors: | PAIVA, Gerson Silva SOUZA, Ivone Antonia de PAVÃO, Antônio Carlos TAFT, Carlton Anthony |
| Issue Date: | 19-Sep-2013 |
| Publisher: | World Intellectual Property Organization (WIPO) |
| Abstract: | The present invention can be used as an antitumour drug for testosterone-dependent tumours, in particular prostate cancer. The invention relates to a molecular compound composed of testosterone molecules chemically bonded to a chemotherapeutic radioactive iodine atom (I-124, 125 or 131) aimed at combating testosterone-dependent tumours, in particular prostate cancer, eliminating the undesirable collateral effect of known chemotherapeutic compounds, which is the destruction of rapid growth cells such as white blood cells. The main contribution of the invention is the use of testosterone as the chemotherapeutic agent carrier. In particular, a testosterone molecule chemically bonded to a radioactive iodine atom is used, which can be iodine-125, 125 or 131. |
| URI: | https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015027307 https://repositorio.ufpe.br/handle/123456789/61774 |
| Appears in Collections: | Patentes |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| WO 2012142687.pdf | 219,08 kB | Adobe PDF |  View/Open |
This item is protected by original copyright |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.